CEDAR KNOLLS, N.J.,
April 10, 2018 /PRNewswire/ -- MYOS
RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a
biotherapeutics and bionutrition company and the owner of
Fortetropin®, a proprietary bioactive composition
derived from fertilized egg yolk that helps build lean muscle in
conjunction with resistance training, announced today that it has
received the prestigious Certified for Sport®
certification from NSF International for its new sports nutrition
product line, "Yolked™".
Yolked™ is a novel advanced nutrition product based on
Fortetropin® that will be marketed specifically to
competitive athletes.
Joseph Mannello, Chief Executive
Officer of MYOS RENS Technology, Inc., stated, "Competitive
athletes work harder than ever before in building lean muscle mass
to gain greater strength, stamina and flexibility. We developed and
formulated Yolked™ specifically to meet the needs of these
athletes. Our goal for Yolked™ products is to have a major presence
in locker rooms and training facilities of collegiate and
professional sports teams."
"Athletic programs demand third party certification to protect
their athletes and the NSF's "Certified for Sport®" certification
is the gold standard. In late 2017, MYOS entered into a strategic
partnership with IMG College, a division of IMG, to market its
products to collegiate athletic programs and their fans. IMG
College has a large national footprint across collegiate athletics
that can open the way for MYOS to reach not only the athletic
departments, but also the faculty and alumni. Importantly,
achieving the Certified for Sport® certification for Yolked™ will
enable MYOS to aggressively execute upon our strategic program with
IMG," continued Mr. Mannello.
"Achieving NSF's Certified for Sport® certification demonstrates
MYOS RENS Technology's commitment to quality, safety and clean
sport," said Brian Jordan, CSCS,
RSCC *D, Technical Manager of NSF International's Certified for
Sport® program. "Consumers can choose Certified for Sport® products
with confidence, knowing that those products have been tested for
harmful levels of contaminants like lead and arsenic as well as
more than 272 athletic banned substances."
The NSF Certified for Sport® Program helps athletes,
coaches and trainers make more educated decisions when choosing
sports supplements. The program is recognized by the NFL, NFL
Players Association, MLB, MLB Players Association, PGA, LPGA and
Canadian Centre for Ethics in Sports.
The Certified for Sport® certification mark on packaging helps
athletes of all levels choose supplements with confidence.
Certified for Sport® supplements must meet rigorous standards that
include comprehensive lab testing and extensive evaluation of the
manufacturing process to ensure contaminated substances or hidden
ingredients are not added to a product. To learn more about the
Certified for Sport® program visit nsfsport.com or download our NSF
Sport app from your app store.
About MYOS RENS Technology Inc.
MYOS RENS
Technology Inc. (MYOS), "The Muscle Company™", is a Cedar Knolls, NJ-based bionutrition company
that develops and markets products that improve muscle health and
performance. MYOS is the owner of Fortetropin®, a fertilized egg
yolk-based product manufactured via a proprietary process to retain
and optimize its biological activity. Fortetropin® has been
clinically shown to increase muscle size and lean body mass in
conjunction with resistance training. MYOS believes Fortetropin®
has the potential to redefine existing standards of physical health
and wellness. For more information, please visit
www.MYOSRENS.com.
Forward-Looking Statements
Any statements
in this release that are not historical facts are forward-looking
statements. Actual results may differ materially from those
projected or implied in any forward-looking statements. Such
statements involve risks and uncertainties, including but not
limited to those relating to product and customer demand, market
acceptance of our products, the ability to create new products
through research and development, the successful results of
strategic initiatives, the successful launch of our products,
including Qurr® products, the success of our research
and development, the results of the clinical evaluation of
Fortetropin® and its effects, the ability to enter into
new partnership opportunities and the success of our existing
partnerships, the ability to generate the forecasted revenue stream
and cash flow from sales of our products, the ability to continue
increasing our revenue and gross profit margins, the ability to
achieve a sustainable, profitable business, the effect of economic
conditions, the ability to protect our intellectual property
rights, competition from other providers and products, the
continued listing of our securities on the Nasdaq Stock Market,
risks in product development, our ability to raise capital to fund
continuing operations, and other factors discussed from time to
time in the Company's Securities and Exchange Commission filings.
The Company undertakes no obligation to update or revise any
forward-looking statement for events or circumstances after
the date on which such statement is made except as required by
law.
These statements have not been evaluated by the Food and Drug
Administration. Our products are not intended to diagnose, treat,
cure or prevent any disease.
Investor
Relations: Porter LeVay
& Rose Michael Porter,
President Phone:
212-564-4700 Email:
MYOS@plrinvest.com
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/myos-rens-technology-introduces-new-sports-nutrition-product-line-yolked-and-earns-prestigious-certified-for-sport-certification-from-nsf-international-300626723.html
SOURCE MYOS RENS Technology Inc.